52532 Federal Register / Vol. 75, No. 165 / Thursday, August 26, 2010 / Notices 

ARRA ADJUSTMENTS TO FMAP Q3 FY10—Continued 

State Hold harmless 

FY10 

Hold harmless 

FY10 FMAP 

with 6.2% pt 

increase 

3rd Quarter 

FY10 

unemployment 

tier 

3rd Quarter 

FY10 

unemployment 

adjustment 

3rd Quarter 

FY10 FMAP 

unemployment 

adjustment 

3rd Quarter 

FY10 FMAP 

unemployment 

hold harmless 

Indiana ......................................... 65.93 72.13 11.5 3.56 75.69 75.69 

Iowa .............................................. 63.51 69.71 8.5 2.84 72.55 72.55 

Kansas ......................................... 60.38 66.58 8.5 3.10 69.68 69.68 

Kentucky ...................................... 70.96 77.16 11.5 2.98 80.14 80.14 

Louisiana ...................................... 72.47 78.67 11.5 2.81 81.48 81.48 

Maine ........................................... 64.99 71.19 11.5 3.67 74.86 74.86 

Maryland ...................................... 50.00 56.20 11.5 5.39 61.59 61.59 

Massachusetts ............................. 50.00 56.20 11.5 5.39 61.59 61.59 

Michigan ....................................... 63.19 69.39 11.5 3.88 73.27 73.27 

Minnesota ..................................... 50.00 56.20 8.5 3.99 60.19 61.59 

Mississippi .................................... 76.29 82.49 11.5 2.37 84.86 84.86 

Missouri ........................................ 64.51 70.71 11.5 3.72 74.43 74.43 

Montana ....................................... 68.53 74.73 11.5 3.26 77.99 77.99 

Nebraska ...................................... 60.56 66.76 5.5 2.00 68.76 68.76 

Nevada ......................................... 52.64 58.84 11.5 5.09 63.93 63.93 

New Hampshire ........................... 50.00 56.20 11.5 5.39 61.59 61.59 

New Jersey .................................. 50.00 56.20 11.5 5.39 61.59 61.59 

New Mexico ................................. 71.35 77.55 11.5 2.94 80.49 80.49 

New York ..................................... 50.00 56.20 11.5 5.39 61.59 61.59 

North Carolina .............................. 65.13 71.33 11.5 3.65 74.98 74.98 

North Dakota ................................ 63.75 69.95 0 0.00 69.95 69.95 

Ohio .............................................. 63.42 69.62 11.5 3.85 73.47 73.47 

Oklahoma ..................................... 67.10 73.30 11.5 3.43 76.73 76.73 

Oregon ......................................... 62.74 68.94 11.5 3.93 72.87 72.87 

Pennsylvania ................................ 54.81 61.01 11.5 4.84 65.85 65.85 

Rhode Island ................................ 52.63 58.83 11.5 5.09 63.92 63.92 

South Carolina ............................. 70.32 76.52 11.5 3.06 79.58 79.58 

South Dakota ............................... 62.72 68.92 5.5 1.88 70.80 70.80 

Tennessee ................................... 65.57 71.77 11.5 3.60 75.37 75.37 

Texas ........................................... 60.56 66.76 11.5 4.18 70.94 70.94 

Utah .............................................. 71.68 77.88 11.5 2.90 80.78 80.78 

Vermont ........................................ 59.45 65.65 8.5 3.18 68.83 69.96 

Virginia ......................................... 50.00 56.20 11.5 5.39 61.59 61.59 

Washington .................................. 51.52 57.72 11.5 5.22 62.94 62.94 

West Virginia ................................ 74.25 80.45 11.5 2.60 83.05 83.05 

Wisconsin ..................................... 60.21 66.41 11.5 4.22 70.63 70.63 

Wyoming ...................................... 50.00 56.20 11.5 5.39 61.59 61.59 

[FR Doc. 2010–21235 Filed 8–25–10; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Vaccine 

Advisory Committee 

AGENCY: Office of Public Health and 

Science, Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice of meeting. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the National Vaccine Advisory 

Committee (NVAC) will hold a meeting. 

The meeting is open to the public. Preregistration is required for both public 

attendance and comment. Individuals 

who wish to attend the meeting and/or 

participate in the public comment 

session should either e-mail 

nvpo@hhs.gov or call 202–690–5566 to 

register. 

DATES: The meeting will be held on 

September 14, 2010, from 8 a.m. to 5 

p.m., and September 15, 2010 from 8 

a.m. to 3 p.m. 

ADDRESSES: Department of Health and 

Human Services; Hubert H. Humphrey 

Building, Great Hall; 200 Independence 

Avenue, SW., Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT: 

National Vaccine Program Office, 

Department of Health and Human 

Services, Room 715–H, Hubert H. 

Humphrey Building, 200 Independence 

Avenue, SW., Washington, DC 20201. 

Phone: (202) 690–5566; Fax: (202) 260– 

1165; e-mail: nvpo@hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 2101 of the Public Health 

Service Act (42 U.S.C. Section 300aa–1), 

the Secretary of Health and Human 

Services was mandated to establish the 

National Vaccine Program to achieve 

optimal prevention of human infectious 

diseases through immunization and to 

achieve optimal prevention against 

adverse reactions to vaccines. The 

National Vaccine Advisory Committee 

was established to provide advice and 

make recommendations to the Director 

of the National Vaccine Program on 

matters related to the Program’s 

responsibilities. The Assistant Secretary 

for Health serves as Director of the 

National Vaccine Program. 

Topics to be discussed at the meeting 

include the 2010–2011 Seasonal Flu 

Campaign, Hepatitis B vaccination, 

Healthy People 2020, vaccine safety, 

and other related issues. The meeting 

agenda will be posted on the Web site: 

http://www.hhs.gov/nvpo/nvac at least 

one week prior to the meeting. Public 

attendance at the meeting is limited to 

space available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the office at the address/phone 

listed above at least one week prior to 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 165 / Thursday, August 26, 2010 / Notices 52533 

the meeting. Members of the public will 

have the opportunity to provide 

comments at the meeting. Public 

comment will be limited to five minutes 

per speaker. Individuals who would like 

to submit written statements should 

e-mail or fax their comments to the 

National Vaccine Program Office at least 

five business days prior to the meeting. 

Those wishing to register to attend the 

meeting may do so by sending an e-mail 

to nvpo@hhs.gov or by calling 202–690– 

5566 and providing name, e-mail 

address and organization. 

Dated: August 23, 2010. 

Bruce Gellin, 

Deputy Assistant Secretary for Health, 

Director, National Vaccine Program Office. 

[FR Doc. 2010–21263 Filed 8–25–10; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Public Meeting of the Presidential 

Commission for the Study of 

Bioethical Issues 

AGENCY: Department of Health and 

Human Services, Office of Public Health 

and Science, The Presidential 

Commission for the Study of Bioethical 

Issues. 

ACTION: Notice of meeting. 

SUMMARY: The Presidential Commission 

for the Study of Bioethical Issues will 

conduct a meeting in September. At this 

meeting, the Commission will continue 

discussing the emerging science of 

synthetic biology, including its potential 

benefits and risks, and appropriate 

ethical boundaries and principles. 

DATES: The meeting will take place 

Monday, September 13, 2010, from 8:50 

a.m. to approximately 4:15 p.m., and 

Tuesday, September 14, 2010, from 9 

a.m. to approximately noon. 

ADDRESSES: Monday, September 13, The 

Inn at Penn, 3600 Sansom Street, 

Philadelphia, PA 19104. Phone 215– 

222–0200. Tuesday, September 14, The 

Annenberg Public Policy Center, 202 

South 36th Street, Philadelphia, PA 

19104. Phone 215–898–9400. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Diane M. Gianelli, Director of 

Communications, The Presidential 

Commission for the Study of Bioethical 

Issues, 1425 New York Avenue, NW., 

Suite C–100, Washington, DC 20005. 

Telephone: 202/233–3960. E-mail: 

info@bioethics.gov. Additional 

information may be obtained by viewing 

the Web site: http://www.bioethics.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to the Federal Advisory Committee Act, 

Public Law 92–463, 5 U.S.C. App., 

notice is hereby given that the 

Presidential Commission for the Study 

of Bioethical Issues (PCSBI) will be 

conducting a meeting. The meeting will 

be held from 8:50 a.m. to approximately 

4:15 p.m. on Monday, September 13, 

2010, at the Inn at Penn, 3600 Sansom 

Street, Philadelphia, PA 19104, and 

from 9 a.m. to approximately noon on 

Tuesday, September 14, 2010, at The 

Annenberg Public Policy Center, 202 

South 36th Street, Philadelphia, PA 

19104. The meeting will be open to the 

public with attendance limited to space 

available. The meeting will also be Web 

cast. 

Under authority of Executive Order 

13521, dated November 24, 2009, the 

President established the PCSBI to serve 

as a public forum and advise him on 

bioethical issues generated by novel and 

emerging research in biomedicine and 

related areas of science and technology. 

The Commission is charged to identify 

and promote policies and practices that 

assure ethically responsible conduct of 

scientific research, healthcare delivery, 

and technological innovation. In 

undertaking these duties, the 

Commission will examine specific 

bioethical, legal, and social issues 

related to potential scientific and 

technological advances; examine 

diverse perspectives and possibilities 

for useful international collaboration on 

these issues, and recommend legal, 

regulatory, or policy actions as 

appropriate. The main agenda items for 

this meeting involve further discussion 

of the opportunities and benefits to the 

public of the emerging science of 

synthetic biology, the challenges and 

risks, and the ethical boundaries that 

may be important to formulation of 

public policy with regard to this 

advancing science. The Commission 

also will hear more from the perspective 

of faith communities and others. The 

draft meeting agenda and other 

information about PCSBI, including 

information about access to the Web 

cast, will be available at http:// 

www.bioethics.gov. 

The Commission welcomes input 

from anyone wishing to provide public 

comment on any issue before it. 

Individuals who would like to provide 

public comment at the meeting should 

notify Ms. Diane Gianelli, Director of 

Communications, by telephone at 202– 

233–3960, or e-mail at 

diane.gianelli@bioethics.gov. Anyone 

planning to attend the meeting who 

needs special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

also notify Ms. Gianelli in advance of 

the meeting. The Commission will make 

every effort to accommodate persons 

who need special assistance. 

Written comments will also be 

accepted in accord with the 

Commission’s existing request for 

public comment on the issues before the 

Commission. Please address written 

comments by e-mail to 

info@bioethics.gov, or by mail to the 

following address: Public Commentary, 

The Presidential Commission for the 

Study of Bioethical Issues, 1425 New 

York Ave., NW., Suite C–100, 

Washington, DC 20005. Comments will 

be publicly available, including any 

personally identifiable or confidential 

business information that they contain. 

Trade secrets should not be submitted. 

Dated: August 17, 2010. 

Valerie H. Bonham, 

Executive Director, The Presidential 

Commission for the Study of Bioethical Issues. 

[FR Doc. 2010–21267 Filed 8–25–10; 8:45 am] 

BILLING CODE 4154–06–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: 

Comment Request 

In compliance with the requirement 

for opportunity for public comment on 

proposed data collection projects 

(section 3506(c)(2)(A) of Title 44, United 

States Code, as amended by the 

Paperwork Reduction Act of 1995, Pub. 

L. 104–13), the Health Resources and 

Services Administration (HRSA) 

publishes periodic summaries of 

proposed projects being developed for 

submission to the Office of Management 

and Budget (OMB) under the Paperwork 

Reduction Act of 1995. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and draft instruments, e-mail 

paperwork@hrsa.gov or call the HRSA 

Reports Clearance Officer at (301) 443– 

1129. 

Comments are invited on: (a) The 

proposed collection of information for 

the proper performance of the functions 

of the agency; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. 

mstockstill on DSKH9S0YB1PROD with NOTICES